Clinical Unit

Biokinetica Clinical Unit

Dedicated Early Phase Clinical Research Infrastructure

Our purpose-built Early Phase Unit, located in the Warsaw region, Poland, is designed to support Phase 1 and complex clinical pharmacology studies. Integrated clinical, laboratory, and pharmacy capabilities enable efficient study conduct, intensive participant monitoring, and reliable data generation.

Clinical Unit Capabilities ​

50-bed clinical pharmacology unit
for Ph1 trials / Józefów near Warsaw

Dedicated prescreening facility

24/7 medical monitoring

In-house pharmacy
and sample processing Lab

5-bed in-house ECU,
direct access to cardiac ECU

In-house fully-equipped
state of the art surgical room

Fully certified for QTc studies

In-house CSF sampling

Hospital-Based Phase 1 Clinical Trial Unit, FDA inspected​

Purpose-Built Phase 1 Infrastructure

Designed for early-phase clinical development, our hospital-based Clinical Research Unit provides the infrastructure required for safe, efficient, and compliant study conduct.

  • 50-bed Clinical Pharmacology Unit located near Warsaw
  • Dedicated prescreening facility
  • Purpose-built environment for Phase 1 and clinical pharmacology studies
  • Direct access to hospital resources and specialist medical support

Advanced Clinical Capabilities for Phase 1 Trials

Our specialized infrastructure supports complex studies requiring intensive monitoring, advanced procedures, and continuous clinical oversight.

  • 5-bed Emergency Care Unit (ECU)
  • Direct access to advanced cardiac care
  • Fully equipped surgical suite for specialized procedures

Integrated Laboratory and Clinical Support

Clinical, pharmacy, and laboratory services work together within one coordinated environment to support efficient study execution and high-quality data generation.

  • In-house pharmacy for investigational product management
  • On-site sample processing laboratory
  • Integrated clinical and laboratory workflows
  • Controlled environment supporting protocol compliance

Operational Excellence & Regulatory Readiness

Robust processes, experienced teams, and continuous oversight support high-quality study conduct and dependable project delivery.

  • FDA-inspected clinical research site
  • Strong regulatory compliance and audit readiness
  • Efficient and predictable study timelines
  • Reliable execution of complex early-phase protocols

Do you have any questions?

To ensure the best possible experience, the website contains cookies. Please read our privacy policy.